These were my notes from KEI’s intervention on April 30, 2026. Thank you for the opportunity to provide comments. This morning, we received the latest version of the Annex. It was 7882 words and 17 pages long, with 450 brackets,… Continue Reading
KEI-CFIUS-Paramount-Global-22April2026 I. PETITION Knowledge Ecology International (KEI) respectfully petitions the Committee on Foreign Investment in the United States (“CFIUS” or the “Committee”), pursuant to Section 721 of the Defense Production Act of 1950, as amended (50 U.S.C. § 4565) and… Continue Reading
On April 20, 2026, Knowledge Ecology International (KEI) submitted comments to the NIH regarding the “Prospective Grant of an Exclusive Patent License: Pigment Epithelium-Derived Factor (PEDF) Peptides and Use for Treating Retinal Degeneration” (91 FR 16205) to Perpetual Biosciences, Inc.… Continue Reading
On March 2, 2026, Knowledge Ecology International (KEI) submitted comments to the National Institutes of Health (NIH) regarding the “Prospective Grant of an Exclusive Patent License: In Vivo Manufactured Anti-CD19 Chimeric Antigen Receptor (CAR) Products for the Treatment or Prevention… Continue Reading
On Wednesday morning, 26 March 2026, Knowledge Ecology International (KEI) delivered the following oral intervention on the PABS Annex drawn from these notes. The onscreen text that the Secretariat just shared for the PABS Annex includes a number of references… Continue Reading
On Monday, 12 January 2026 a division bench of the Delhi High Court comprised of Justice Hari Shankar and Justice Om Prakash Shukla approved the sale of a biosmilar version of nivolumab, a cancer drug marketed by the firm Zydus… Continue Reading
In 2002, I presented a proposal for a sui generis right for traditional knowledge or access to genetic resources, that would be consistent with more competition and openness. The proposal was modeled after a 1998 EU Directive on Biotechnology, and… Continue Reading
On Friday, 13 February 2026, Knowledge Ecology International (KEI) delivered the following statement during the afternoon session with Relevant Stakeholders, which took place at WHO headquarters from 17:00 CET. If benefit sharing is implemented through contracts, user registration is essential,… Continue Reading
Among issues dividing negotiators on the WHO Pandemic Agreement Annex on Pathogen Access and Benefit Sharing (PABS) are conditions imposed to obtain access to information through the system. One issue that seems basic is whether researchers will have to register… Continue Reading
On Wednesday, 4 February 2026, Knowledge Ecology International (KEI) delivered this constituency statement on behalf of KEI, Health Action International, Global Health Council, World Council of Churches, and Oxfam International: WHO’s work in health emergencies. Our joint statement focused on… Continue Reading